Tier 5pressApprovedev-us-zbh-rosa
Zimmer Biomet receives FDA clearance for ROSA Knee with OptimiZe
Zimmer Biomet Holdings, Inc. (investor relations announcement)
Summary
Zimmer Biomet received FDA 510(k) clearance for ROSA Knee with OptimiZe on 14 November 2025, adding customisable surgeon profiles and automated implant positioning and balancing for functional alignment, with targeted release later that year.
Supporting location Clearance paragraph
Open sourcePublished
14 Nov 2025
Applicable from
—
Accessed
27 Aug 2026
Answers depending on this record
No current answer cites this record.